Home   Kent Business   County news   Article

Centauri Therapeutics given nearly £1m government grant for drug-resistant bacteria research

By Chris Price

A biotechnology company has been awarded up to £945,000 to continue its research into treatment for infectious diseases.

Centauri Therapeutics, based in Discovery Park, Sandwich, has been given the money for its work helping patients suffering from infections caused by drug-resistant bacteria.

It was awarded the cash from the government’s Innovate UK agency as part of a programme aimed at beating gram-negative bacteria, which are a major cause of deaths in patients who contract pneumonia at hospital.

Centauri Therapeutics has been awarded nearly £1 million to continue its research into treatments for drug-resistant bacteria

Centauri Therapeutics has been awarded nearly £1 million to continue its research into treatments for drug-resistant bacteria

Centauri’s Alphamer drug mechanism injects manufactured molecules into the body to encourage natural antibodies to attack pathogens – effectively helping the immune system to fight diseases.

Unlike traditional vaccines, this approach aims to treat infected patients and generates a stronger response from the body.

Its latest round of research – which is expected to take two years – is expected to cost nearly £1.4 million, with the rest of the costs covered by the company’s existing investors.

Centauri chief executive Dr Mike Westby said the cash injection showed the government’s confidence in the company’s techniques.

He added: “The lack of new antibiotics combined with increasing incidence of bacterial resistance in the clinic has been termed ‘the perfect storm’ and there is an urgent need for innovative methods and efficacious therapies.”

Join the debate...
Comments |

Don't have an account? Please Register first!

The KM Group does not moderate comments. Please click here for our house rules.

People who post abusive comments about other users or those featured in articles will be banned.

Thank you. Your comment has been received and will appear on the site shortly.

 

Terms of Comments
We do not actively moderate, monitor or edit contributions to the reader comments but we may intervene and take such action as we think necessary, please click here for our house rules. If you have any concerns over the contents on our site, please either register those concerns using the report abuse button, contact us here, email multimediadesk@thekmgroup.co.uk or call 01634 227989.

Close This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.Learn More